| Alexandria Lynn Kohn, FNP-C | |
|
711 N Sioux Point Rd, Suite 100, Dakota Dunes, SD 57049-5067 | |
| (712) 222-7960 | |
| (472) 222-7961 |
| Full Name | Alexandria Lynn Kohn |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 7 Years |
| Location | 711 N Sioux Point Rd, Dakota Dunes, South Dakota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013427640 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Recover Health | Sioux city, IA | Home health agency |
| St Lukes Regional Medical Center | Sioux city, IA | Hospital |
| Mercyone Siouxland | Sioux city, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Adio Chiropractic Llc | 9931443678 | 2 |
| Curana Health Of Iowa Pllc | 9133536113 | 59 |
News Archive
Two major new research centres at The University of Manchester aimed at improving the lives of people with arthritis are to be officially launched on May 19.
A study from EPFL's (Ecole Polytechnique F-d-rale de Lausanne) Laboratory of Neuroenergetics and Cellular Dynamics in Lausanne Switzerland, published today in the Journal of Neuroscience, may lead to new forms of treatment following a better understanding of how Amyloid-Beta found in cerebral plaques, typically present in the brain of Alzheimer's patients, may lead to neurodegeneration.
BioDelivery Sciences International, Inc. announced the approval by the U.S. Food and Drug Administration of a Supplemental New Drug Application (sNDA) for a new formulation of ONSOLIS (fentanyl buccal soluble film) CII for the management of breakthrough pain in patients with cancer who are opioid tolerant.
If hospital doctors around the world often struggle to become those health centaurs, half professionals and half managers, that modern healthcare organizations need, the main responsibility is not their resistance to change, but the lack of effective support from the organization, according to a study by Marco Sartirana (CERGAS, Bocconi University), Graeme Currie (Warwick Business School), and Mirko Noordegraaf (Utrecht School of Governance), published by the Public Management Review.
CEVEC Pharmaceuticals GmbH, the expert in the production of tailor-made recombinant glycoproteins and gene therapy vectors, today announced the introduction of its unique cell-expression system, CAP GT, for the fully scalable production of gene therapy vectors, based on the Company's proprietary CAP technology.
› Verified 7 days ago
| Entity Name | Mercy Medical Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134161151 PECOS PAC ID: 5799694063 Enrollment ID: O20031118000075 |
News Archive
Two major new research centres at The University of Manchester aimed at improving the lives of people with arthritis are to be officially launched on May 19.
A study from EPFL's (Ecole Polytechnique F-d-rale de Lausanne) Laboratory of Neuroenergetics and Cellular Dynamics in Lausanne Switzerland, published today in the Journal of Neuroscience, may lead to new forms of treatment following a better understanding of how Amyloid-Beta found in cerebral plaques, typically present in the brain of Alzheimer's patients, may lead to neurodegeneration.
BioDelivery Sciences International, Inc. announced the approval by the U.S. Food and Drug Administration of a Supplemental New Drug Application (sNDA) for a new formulation of ONSOLIS (fentanyl buccal soluble film) CII for the management of breakthrough pain in patients with cancer who are opioid tolerant.
If hospital doctors around the world often struggle to become those health centaurs, half professionals and half managers, that modern healthcare organizations need, the main responsibility is not their resistance to change, but the lack of effective support from the organization, according to a study by Marco Sartirana (CERGAS, Bocconi University), Graeme Currie (Warwick Business School), and Mirko Noordegraaf (Utrecht School of Governance), published by the Public Management Review.
CEVEC Pharmaceuticals GmbH, the expert in the production of tailor-made recombinant glycoproteins and gene therapy vectors, today announced the introduction of its unique cell-expression system, CAP GT, for the fully scalable production of gene therapy vectors, based on the Company's proprietary CAP technology.
› Verified 7 days ago
| Entity Name | Adio Chiropractic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043787914 PECOS PAC ID: 9931443678 Enrollment ID: O20181206000604 |
News Archive
Two major new research centres at The University of Manchester aimed at improving the lives of people with arthritis are to be officially launched on May 19.
A study from EPFL's (Ecole Polytechnique F-d-rale de Lausanne) Laboratory of Neuroenergetics and Cellular Dynamics in Lausanne Switzerland, published today in the Journal of Neuroscience, may lead to new forms of treatment following a better understanding of how Amyloid-Beta found in cerebral plaques, typically present in the brain of Alzheimer's patients, may lead to neurodegeneration.
BioDelivery Sciences International, Inc. announced the approval by the U.S. Food and Drug Administration of a Supplemental New Drug Application (sNDA) for a new formulation of ONSOLIS (fentanyl buccal soluble film) CII for the management of breakthrough pain in patients with cancer who are opioid tolerant.
If hospital doctors around the world often struggle to become those health centaurs, half professionals and half managers, that modern healthcare organizations need, the main responsibility is not their resistance to change, but the lack of effective support from the organization, according to a study by Marco Sartirana (CERGAS, Bocconi University), Graeme Currie (Warwick Business School), and Mirko Noordegraaf (Utrecht School of Governance), published by the Public Management Review.
CEVEC Pharmaceuticals GmbH, the expert in the production of tailor-made recombinant glycoproteins and gene therapy vectors, today announced the introduction of its unique cell-expression system, CAP GT, for the fully scalable production of gene therapy vectors, based on the Company's proprietary CAP technology.
› Verified 7 days ago
| Entity Name | Curana Health Of Iowa Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730773714 PECOS PAC ID: 9133536113 Enrollment ID: O20210319000455 |
News Archive
Two major new research centres at The University of Manchester aimed at improving the lives of people with arthritis are to be officially launched on May 19.
A study from EPFL's (Ecole Polytechnique F-d-rale de Lausanne) Laboratory of Neuroenergetics and Cellular Dynamics in Lausanne Switzerland, published today in the Journal of Neuroscience, may lead to new forms of treatment following a better understanding of how Amyloid-Beta found in cerebral plaques, typically present in the brain of Alzheimer's patients, may lead to neurodegeneration.
BioDelivery Sciences International, Inc. announced the approval by the U.S. Food and Drug Administration of a Supplemental New Drug Application (sNDA) for a new formulation of ONSOLIS (fentanyl buccal soluble film) CII for the management of breakthrough pain in patients with cancer who are opioid tolerant.
If hospital doctors around the world often struggle to become those health centaurs, half professionals and half managers, that modern healthcare organizations need, the main responsibility is not their resistance to change, but the lack of effective support from the organization, according to a study by Marco Sartirana (CERGAS, Bocconi University), Graeme Currie (Warwick Business School), and Mirko Noordegraaf (Utrecht School of Governance), published by the Public Management Review.
CEVEC Pharmaceuticals GmbH, the expert in the production of tailor-made recombinant glycoproteins and gene therapy vectors, today announced the introduction of its unique cell-expression system, CAP GT, for the fully scalable production of gene therapy vectors, based on the Company's proprietary CAP technology.
› Verified 7 days ago
| Entity Name | Iowa Care Services, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881269330 PECOS PAC ID: 6709280365 Enrollment ID: O20210804003431 |
News Archive
Two major new research centres at The University of Manchester aimed at improving the lives of people with arthritis are to be officially launched on May 19.
A study from EPFL's (Ecole Polytechnique F-d-rale de Lausanne) Laboratory of Neuroenergetics and Cellular Dynamics in Lausanne Switzerland, published today in the Journal of Neuroscience, may lead to new forms of treatment following a better understanding of how Amyloid-Beta found in cerebral plaques, typically present in the brain of Alzheimer's patients, may lead to neurodegeneration.
BioDelivery Sciences International, Inc. announced the approval by the U.S. Food and Drug Administration of a Supplemental New Drug Application (sNDA) for a new formulation of ONSOLIS (fentanyl buccal soluble film) CII for the management of breakthrough pain in patients with cancer who are opioid tolerant.
If hospital doctors around the world often struggle to become those health centaurs, half professionals and half managers, that modern healthcare organizations need, the main responsibility is not their resistance to change, but the lack of effective support from the organization, according to a study by Marco Sartirana (CERGAS, Bocconi University), Graeme Currie (Warwick Business School), and Mirko Noordegraaf (Utrecht School of Governance), published by the Public Management Review.
CEVEC Pharmaceuticals GmbH, the expert in the production of tailor-made recombinant glycoproteins and gene therapy vectors, today announced the introduction of its unique cell-expression system, CAP GT, for the fully scalable production of gene therapy vectors, based on the Company's proprietary CAP technology.
› Verified 7 days ago
| Entity Name | Ch Specialty Services Ia Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942909353 PECOS PAC ID: 2466826102 Enrollment ID: O20230321002031 |
News Archive
Two major new research centres at The University of Manchester aimed at improving the lives of people with arthritis are to be officially launched on May 19.
A study from EPFL's (Ecole Polytechnique F-d-rale de Lausanne) Laboratory of Neuroenergetics and Cellular Dynamics in Lausanne Switzerland, published today in the Journal of Neuroscience, may lead to new forms of treatment following a better understanding of how Amyloid-Beta found in cerebral plaques, typically present in the brain of Alzheimer's patients, may lead to neurodegeneration.
BioDelivery Sciences International, Inc. announced the approval by the U.S. Food and Drug Administration of a Supplemental New Drug Application (sNDA) for a new formulation of ONSOLIS (fentanyl buccal soluble film) CII for the management of breakthrough pain in patients with cancer who are opioid tolerant.
If hospital doctors around the world often struggle to become those health centaurs, half professionals and half managers, that modern healthcare organizations need, the main responsibility is not their resistance to change, but the lack of effective support from the organization, according to a study by Marco Sartirana (CERGAS, Bocconi University), Graeme Currie (Warwick Business School), and Mirko Noordegraaf (Utrecht School of Governance), published by the Public Management Review.
CEVEC Pharmaceuticals GmbH, the expert in the production of tailor-made recombinant glycoproteins and gene therapy vectors, today announced the introduction of its unique cell-expression system, CAP GT, for the fully scalable production of gene therapy vectors, based on the Company's proprietary CAP technology.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alexandria Lynn Kohn, FNP-C 600 1st St Nw, Suite 101, Mason City, IA 50401-2932 Ph: (712) 203-1640 | Alexandria Lynn Kohn, FNP-C 711 N Sioux Point Rd, Suite 100, Dakota Dunes, SD 57049-5067 Ph: (712) 222-7960 |
News Archive
Two major new research centres at The University of Manchester aimed at improving the lives of people with arthritis are to be officially launched on May 19.
A study from EPFL's (Ecole Polytechnique F-d-rale de Lausanne) Laboratory of Neuroenergetics and Cellular Dynamics in Lausanne Switzerland, published today in the Journal of Neuroscience, may lead to new forms of treatment following a better understanding of how Amyloid-Beta found in cerebral plaques, typically present in the brain of Alzheimer's patients, may lead to neurodegeneration.
BioDelivery Sciences International, Inc. announced the approval by the U.S. Food and Drug Administration of a Supplemental New Drug Application (sNDA) for a new formulation of ONSOLIS (fentanyl buccal soluble film) CII for the management of breakthrough pain in patients with cancer who are opioid tolerant.
If hospital doctors around the world often struggle to become those health centaurs, half professionals and half managers, that modern healthcare organizations need, the main responsibility is not their resistance to change, but the lack of effective support from the organization, according to a study by Marco Sartirana (CERGAS, Bocconi University), Graeme Currie (Warwick Business School), and Mirko Noordegraaf (Utrecht School of Governance), published by the Public Management Review.
CEVEC Pharmaceuticals GmbH, the expert in the production of tailor-made recombinant glycoproteins and gene therapy vectors, today announced the introduction of its unique cell-expression system, CAP GT, for the fully scalable production of gene therapy vectors, based on the Company's proprietary CAP technology.
› Verified 7 days ago
Ellen T Wengert, NP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 705 N Sioux Point Rd, Suite 100, Dakota Dunes, SD 57049 Phone: 605-217-5500 Fax: 605-217-5515 | |
Nicolle Marie Weaver, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 575 N Sioux Point Rd, Dakota Dunes, SD 57049 Phone: 605-217-2667 Fax: 605-217-2900 | |
Mrs. Rayna Lea Bernadine Mccormick, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 575 N Sioux Point Rd, Dakota Dunes, SD 57049 Phone: 605-217-2667 Fax: 605-217-2900 | |
Brooke Buum, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 101 Tower Rd Ste 120, Dakota Dunes, SD 57049 Phone: 605-217-4320 Fax: 605-217-2948 | |
Sandra Louise Shumaker, ACNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 921 Spyglass Cir, Cnos, Pc, Dakota Dunes, SD 57049 Phone: 712-490-8422 | |
Allison Faye Pedersen, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 575 N Sioux Point Rd, Dakota Dunes, SD 57049 Phone: 605-217-2667 Fax: 605-217-2900 |